Open AccessMore than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
Author(s) -
Maria Fleseriu,
Dagmar FührerSakel,
A. J. van der Lely,
Laura De Marinis,
Thierry Brue,
Joli van der Lans-Bussemaker,
Judith HeyHadavi,
Cecilia CamachoHübner,
Michael P. Wajnrajch,
Srinivas Rao Valluri,
Andrew Palladino,
Roy Gomez,
Roberto Salvatori
Publication year - 2021
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-21-0239
Subject(s) - pegvisomant , acromegaly , medicine , endocrinology , growth hormone , hormone
To report the final long-term safety and efficacy analyses of patients with acromegaly treated with pegvisomant from the ACROSTUDY.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom